Search for: "WYETH PHARMACEUTICALS INC"
Results 361 - 380
of 515
Sort by Relevance
|
Sort by Date
14 Oct 2009, 12:31 pm
On October 14, 2009, the Federal Trade Commission (“FTC”) settled with Pfizer Inc. regarding its proposed $68 billion acquisition of Wyeth. [read post]
14 Oct 2009, 6:26 am
Pfizer's Acquisition of Wyeth Clears Antitrust HurdlesThis posting was written by Jeffrey May, Editor of CCH Trade Regulation Reporter.Pfizer, Inc.'s proposed $68 billion acquisition of Wyeth was conditionally approved by the Federal Trade Commission (FTC) today. [read post]
1 Oct 2009, 2:14 am
Mylan Pharmaceuticals, 2008 WL 3540462 (N.D.W. [read post]
30 Sep 2009, 12:29 am
Wyeth Pharmaceuticals Inc., 040406301, Court of Common Pleas, Philadelphia County, Pennsylvania. [read post]
18 Sep 2009, 2:40 am
Here are excerpts from the aticle: The drug, previously sold by Wyeth Pharmaceuticals Inc. under the brand name Phenergan, was at the heart of a U.S. [read post]
17 Sep 2009, 1:11 pm
The drug, previously sold by Wyeth Pharmaceuticals Inc. under the brand name Phenergan, was at the heart of a U.S. [read post]
17 Sep 2009, 7:08 am
Makers of injected promethazine, a sedative also used to treat nausea and vomiting, are being required to put the strongest warning possible on the product because it can cause tissue damage leading to amputation, the Food and Drug Administration said Wednesday.The drug, previously sold by Wyeth Pharmaceuticals Inc. under the brand name Phenergan, was at the heart of a U.S. [read post]
17 Sep 2009, 4:30 am
Medtronic, Inc., 128 S. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs) Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
7 Sep 2009, 12:35 pm
The Court discussed several different subsidiaries in the U.S. and in Europe that use very similar variations on the name Wyeth Pharmaceutical, such as Wyeth Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Limited. [read post]
2 Sep 2009, 11:22 pm
Fujisawa Pharmaceutical Co., 464 F. [read post]
16 Aug 2009, 11:23 am
The best example of the downside of optionality was the sale of United Rentals Inc. where the buyer, Cerberus, unabashedly chose to pay the break fee rather than close, despite the absence of any material problem in the URI business. [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan… [read post]
3 Aug 2009, 7:29 am
All responding defendants (Actavis, Inc.; Actavis-Elizabeth, L.L.C.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.; Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff from Vermont. [read post]
30 Jul 2009, 8:49 pm
By Sydney Kokjohn -- Fish & Richardson and its pharmaceutical client Japan Tobacco Inc. recently discovered another error in the U.S. [read post]
22 Jul 2009, 10:59 am
Fish & Richardson and their pharmaceutical client Japan Tobacco Inc. [read post]
20 Jul 2009, 10:00 pm
Liggett Group, Inc., the U.S. [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
9 Jul 2009, 4:54 am
Merrrell Dow Pharmaceuticals, Inc., 509 U .S. 579 (1993). [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs) Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi… [read post]
